CureVac N.V. (BIT:1CVAC)

Italy flag Italy · Delayed Price · Currency is EUR
4.656
0.00 (0.00%)
At close: Jul 18, 2025, 5:30 PM CET
Market Cap1.04B
Revenue (ttm)523.70M
Net Income (ttm)180.66M
Shares Outn/a
EPS (ttm)0.80
PE Ratio5.74
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume11
Open4.656
Previous Close4.656
Day's Range4.656 - 4.656
52-Week Range2.146 - 4.952
Betan/a
RSI60.33
Earnings DateAug 15, 2025

About CureVac

CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). The company’s portfolio includes clinical and preclinical candidates for various disease indications in prophylactic vaccines, oncology, and molecular therapy. It also delivers optimized mRNAs to stimulate the production of therapeutic proteins utilizing its technology and instructs human cells to produce or secrete specific proteins in the nucleus, cytoplasm, cellular organelles, and cell membrane. In ad... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Employees 983
Stock Exchange Borsa Italiana
Ticker Symbol 1CVAC
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.